close
PR
Parenchyma Biotech Development pipeline
PUBLICATIONS & PATENTS
Aryl hydrocarbon receptor–targeted therapy for CD4 T cell–mediated idiopathic pneumonia syndrome in mice
2023-06-08
Immune regulation through tryptophan metabolism
2023-07-03